600671 天目药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)23.88534.061-339.450-441.328-50.499
总资产报酬率 ROA (%)3.2623.871-11.798-19.148-7.052
投入资产回报率 ROIC (%)6.0458.055-28.512-49.337-16.531

边际利润分析
销售毛利率 (%)46.37847.38021.78722.93431.224
营业利润率 (%)4.50111.557-30.851-64.168-25.840
息税前利润/营业总收入 (%)9.42015.771-23.961-59.650-17.903
净利润/营业总收入 (%)4.72410.062-32.268-67.143-22.290

收益指标分析
经营活动净收益/利润总额(%)98.88697.72681.95350.76081.058
价值变动净收益/利润总额(%)0.0400.0991.448-1.3330.000
营业外收支净额/利润总额(%)28.47313.618-3.4683.431-12.650

偿债能力分析
流动比率 (X)0.8070.7780.8240.5610.741
速动比率 (X)0.6550.5950.6290.3460.532
资产负债率 (%)78.05780.74283.84398.49383.967
带息债务/全部投入资本 (%)48.72944.11732.81442.97819.740
股东权益/带息债务 (%)54.44454.19070.998-31.116139.042
股东权益/负债合计 (%)19.85314.69612.791-4.89513.364
利息保障倍数 (X)3.0126.594-4.092-8.776-3.556

营运能力分析
应收账款周转天数 (天)211.822110.37899.756135.909116.637
存货周转天数 (天)148.613149.976171.044214.290213.315